Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer

Open access

Abstract

BACKGROUND: Breast-conservation therapy for early-stage breast cancer is now an accepted treatment, but there is still controversy about its comparability with mastectomy. Between 1979 and 1987, the National Cancer Institute conducted a randomized, single-institution trial comparing lumpectomy, axillary dissection, and radiation with mastectomy and axillary dissection for stage I and II breast cancer. We update the results of that trial after a median potential follow-up of 10.1 years. METHODS: Two hundred forty-seven patients with clinical stage I and II breast cancer were randomly assigned to undergo either modified radical mastectomy or lumpectomy, axillary dissection, and radiation therapy. The 237 patients who actually underwent randomization have been followed for a median of 10.1 years. The primary end points were overall survival and disease-free survival. RESULTS: At 10 years overall survival was 75 percent for the patients assigned to mastectomy and 77 percent for those assigned to lumpectomy plus radiation (P = 0.89). Disease-free survival at 10 years was 69 percent for the patients assigned to mastectomy and 72 percent for those assigned to lumpectomy plus radiation (P = 0.93). The rate of local regional recurrence at 10 years was 10 percent after mastectomy and 5 percent after lumpectomy plus radiation (P = 0.17) after recurrences successfully treated by mastectomy were censored from the analysis. CONCLUSIONS: In the management of stage I and II breast cancer, breast conservation with lumpectomy and radiation offers results at 10 years that are equivalent to those with mastectomy.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199504063321402

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Research works printed but not linked: 6

  1. van Dongen JA, 1992, Monogr Natl Cancer Inst, 11, 15
  2. Blichert-Toft M, 1992, Monogr Natl Cancer Inst, 11, 19
  3. Straus K, 1992, Monogr Natl Cancer Inst, 11, 27
  4. Lippman ME, 1986, Monogr Natl Cancer Inst, 1, 99
  5. 10.2307/2281868 · doi:10.2307/2281868 · Paper page
  6. 10.1002/1097-0142(19891201)64:11<2217::AID-CNCR2820641106>3.0.CO;2-2 · doi:10.1002/1097-0142(19891201)64:11<2217::aid-cncr2820641106>3.0.co;2-2

Cited by

See all 892

Metadata

Authors
Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E., & Okunieff, P.
Affiliations
  • National Institutes of Health (US)
  • National Cancer Institute (US)
  • University of Michigan (US)
  • Georgetown University (US)
  • Harold C. Simmons Comprehensive Cancer Center (US)
Venue
New England Journal of Medicine
Published
1995-04-06
Volume
332
Issue
14
Pages
907-911
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1982623790
Cited by
892
References
23
Citations by year
2026: 7 · 2025: 6 · 2024: 12 · 2023: 21 · 2022: 25 · 2021: 22 · 2020: 27 · 2019: 14 · 2018: 16 · 2017: 25 · 2016: 23 · 2015: 24 · 2014: 31 · 2013: 29 · 2012: 38
FWCI
12.04
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
breast-conserving therapy, breast-conserving surgery, mastectomy, early breast cancer, axillary lymph node dissection, radiotherapy, overall survival, disease-free survival, local recurrence, long-term follow-up
MeSH terms
Breast Neoplasms, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Lymph Node Excision, Mastectomy, Modified Radical, Mastectomy, Segmental, Chemotherapy, Adjuvant, Treatment Failure, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer. https://app.cochat.ai/papers/10.1056/nejm199504063321402
The paper
Jacobson, J. A., Danforth, D. N., Cowan, K. H., d'Angelo, T., Steinberg, S. M., Pierce, L., Lippman, M. E., Lichter, A. S., Glatstein, E., & Okunieff, P. (1995). Ten-Year Results of a Comparison of Conservation with Mastectomy in the Treatment of Stage I and II Breast Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejm199504063321402

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.